Condition: Oral and Throat Cancer · Oropharyngeal Squamous Cell Carcinoma · Oral Squamous Cell Carcinoma · Sponsor: Viome
A total of at least 1,000 participants with suspicion of cancer including at least 107 subjects who will be diagnosed with OSCC or OPSCC will be enrolled from either primary or secondary care centers in the U.S. Clinicians will use Viome collection kits to collect saliva samples from eligible patients.
This description comes directly from the study's public registry record.
Mory Mehrtash · 425-300-6933 · studies@viome.com
Momchilo Vuyisich · 425-300-6933 · studies@viome.com
Always discuss trial participation with your own doctor first.
| Missouri School of Dentistry & Oral Health | St Louis, Missouri, United States | Recruiting |
| UTHSC | Memphis, Tennessee, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06174428